AI assistant
Sending…
Luye Pharma Group Limited — Earnings Release 2000
Aug 2, 2000
50431_rns_2000-08-02_3cb68ff7-3c57-454e-999c-dc7e2455b893.htm
Earnings Release
Open in viewerOpens in your device viewer
Listed Company Information
![]() |
| TAKSON HOLDINGS<0918> - Results Announcement Takson Holdings Limited announced on 2/8/2000: (stock code: 918) Year end date: 31/3/2000 Currency: HK$ (Audited) (Audited) Last Current Corresponding Period Period from 1/4/1999 from 1/4/1998 to 31/3/2000 to 31/3/1999 ('000) ('000) Turnover - Continuing : 480,713 357,221 - Discontinued : - - Operating Profit/(Loss) - Continuing : 60,905 51,734 - Discontinued : - - Total Operating Profit/(Loss) : 60,905 51,734 Share of Profit/(Loss) of Associated Companies : - - Share of Profit/(Loss) of Jointly Controlled Entities : (195) - Profit/(Loss) after Tax & MI : 50,425 47,879 % Change over Last Period : +5% EPS/(LPS)-Basic : 13.9 cents 13.3 cents -Diluted : 13.0 cents 13.0 cents Extraordinary (ETD) Gain/(Loss) : - - Profit/(Loss) after ETD Items : 50,425 47,879 Final Dividend per Share : 11 cents 5 cents (Specify if with other options) : - - B/C Dates for Final Dividend : 13/9/2000 to 15/9/2000 bdi. Payable Date : 20/9/2000 B/C Dates for Annual General Meeting : 13/9/2000 to 15/9/2000 bdi. Other Distribution for Current Period : - B/C Dates for Other Distribution : - Remark: Earnings per share The calculation of basic and diluted earnings per share are based on the Group's profit attributable to shareholders of HK$50,425,000 (1999: HK$47,879,000). The basic earnings per share is based on the weighted average of 363,529,372 (1999: 360,000,000) ordinary shares in issue during the year. The diluted earnings per share is based on 363,529,372 (1999: 360,000,000) ordinary shares which is the weighted average number of ordinary shares in issue during the year plus the weighted average of 23,988,032 (1999: 7,741,276) ordinary shares deemed to be issued at no consideration if all outstanding options had been exercised. |
More from Luye Pharma Group Limited
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Proxy Solicitation & Information Statement
2026
May 29
Regulatory Filings
2026
May 7
Environmental & Social Information
2026
Apr 29
Regulatory Filings
2026
Apr 20
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Apr 8
Earnings Release
2026
Mar 31
